Thomas Reiner

Near-infrared fluorescent probe for imaging of pancreatic beta cells.

Bioorthogonal small-molecule ligands for PARP1 imaging in living cells.

High-Yielding, Two-Step (18)F Labeling Strategy for (18)F-PARP1 Inhibitors.

Synthesis and in vivo imaging of a 18F-labeled PARP1 inhibitor using a chemically orthogonal scavenger-assisted high-performance method.

High-yielding, two-step 18F labeling strategy for 18F-PARP1 inhibitors.

Towards quantitative catalytic lignin depolymerization.

In vivo PET imaging of histone deacetylases by 18F-suberoylanilide hydroxamic acid (18F-SAHA).

Accurate measurement of pancreatic islet beta-cell mass using a second-generation fluorescent exendin-4 analog.

Bioorthogonal probes for polo-like kinase 1 imaging and quantification.

Nanoparticle-mediated measurement of target-drug binding in cancer cells.

Ubiquitous detection of gram-positive bacteria with bioorthogonal magnetofluorescent nanoparticles.

Specific pathogen detection using bioorthogonal chemistry and diagnostic magnetic resonance.

Imaging therapeutic PARP inhibition in vivo through bioorthogonally developed companion imaging agents.

Bioorthogonal imaging of aurora kinase A in live cells.

Microfluidic cell sorter (μFCS) for on-chip capture and analysis of single cells.

Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo.

Phenylalanine--a biogenic ligand with flexible η6- and η6:κ1-coordination at ruthenium(II) centres.

A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels-Alder Click Chemistry.

Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detection.

Efficient (18)F-Labeling of Synthetic Exendin-4 Analogues for Imaging Beta Cells.

(18)F-labeled-bioorthogonal liposomes for in vivo targeting.

The inverse electron demand Diels-Alder click reaction in radiochemistry.

Metal-conjugated affinity labels: a new concept to create enantioselective artificial metalloenzymes.

Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitors.

Efficient acid-catalyzed (18) F/(19) F fluoride exchange of BODIPY dyes.

Building Blocks for the Construction of Bioorthogonally Reactive Peptides via Solid-Phase Peptide Synthesis.

In vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agent.

Synthesis of the first radiolabeled 188Re N-heterocyclic carbene complex and initial studies on its potential use in radiopharmaceutical applications.

PARPi-FL--a fluorescent PARP1 inhibitor for glioblastoma imaging.

A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting.

Cerenkov Luminescence Imaging for Radiation Dose Calculation of a ⁹⁰Y-Labeled Gastrin-Releasing Peptide Receptor Antagonist.

Dual-Modality Optical/PET Imaging of PARP1 in Glioblastoma.

PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles.

Development of a clickable bimodal fluorescent/PET probe for in vivo imaging.

Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.

Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation.

Radioiodinated PARP1 tracers for glioblastoma imaging.

(18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry.

Non-invasive PET Imaging of PARP1 Expression in Glioblastoma Models.

Optical Imaging of PARP1 in Response to Radiation in Oral Squamous Cell Carcinoma.

Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent.

In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.

Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.

Near-Infrared Intraoperative Chemiluminescence Imaging.

Immune cell screening of a nanoparticle library improves atherosclerosis therapy.

Imaging-guided revival of nanomedicine?

A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer.

Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease.

Biomarker based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models.

Evaluation of [(18)F]-ATRi as PET tracer for in vivo imaging of ATR in mouse models of brain cancer.

Development of a New Folate-Derived Ga-68-Based PET Imaging Agent.